Clinuvel Pharmaceuticals Ltd Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Clinuvel Pharmaceuticals Ltd

CLVLY 8.750

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: caly who wrote (13)	4/26/2007 12:08:38 AM
From: caly	Read Replies (1) of 52

Clinuvel completes A$26 million Private Placement and announces a Share Purchase Plan for Australian investors Clinuvel Pharmaceuticals Limited (ASX:CUV, XETRA-DAX:UR9) is pleased to announce the completion of a successful private placement of 24,339,054 shares at $1.07, to Australian and European institutions resulting in a total of A$26 million. Clinuvel also announces a Share Purchase Plan (SPP) to allow Australian shareholders to participate at the same price. The proceeds will be used to fund clinical trials of CUV1647 in the recently announced fifth indication in Photodynamic Therapy and to continue ongoing development of its technology. ept.irmau.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next